Don't know what 'yahoo board' you are referring to, and I've never shorted this stock. I'm an end user of the product, all I'm saying is that real world efficacy (ie. what I and plenty of other colleagues of mine are seeing) doesn't in any way match the results of the clinical trial. Last I checked this was 'investors hub' not 'clinical trial hub'. Sorry you lost your pants on this stock, but I'm just giving an alternative opinion for why this went from 13 to 36 to 13 in a year that doesn't revolve around 'foley's an idiot' and 'marketing fail'.
News 
Market Data 
Discover 
